Do I remember correctly (cause sometimes I have CRS disease), but did someone from Antares on a call or conference say with respect to EU, they are leaning towards waiting for FDA approval which then would make it easier and potentially more profitable when seeking partnerships? Or did someone from the board say that?
News 
Market Data 
Discover 
AI
